Innovative malaria prodrug targets liver, enhances efficacy while reducing toxicity, preclinical studies show

Tafenoquine, a prodrug that could fulfill the criteria for a mass eradication campaign.

First U.S. Case of Bird Flu in a Pig Raises Concerns Over Threat to Humans

A pig at an Oregon farm was found to have bird flu, the U.S. Department of Agriculture (USDA) announced Wednesday. It’s the first time the

November 1, 2024

Home-Based Phototherapy for Psoriasis Matches Office Efficacy With Better QOL

SAN DIEGO — Home-based phototherapy for psoriasis achieved outcomes similar to office-based therapy, suggesting a potential for more convenient, less expensive treatment for some patients,

March 12, 2024

Updated: Even with no primary endpoint data, TauRx still eyes Alzheimer’s filing after PhIII update

Despite its inability to conduct a Phase III primary analysis, TauRx is planning regulatory filings for its tau aggregation inhibitor in Alzheimer’s disease after reporting

March 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.